vs

Side-by-side financial comparison of BT Brands, Inc. (BTBD) and Vivos Therapeutics, Inc. (VVOS). Click either name above to swap in a different company.

BT Brands, Inc. is the larger business by last-quarter revenue ($3.9M vs $3.8M, roughly 1.0× Vivos Therapeutics, Inc.). BT Brands, Inc. runs the higher net margin — 23.7% vs -180.3%, a 204.0% gap on every dollar of revenue. On growth, Vivos Therapeutics, Inc. posted the faster year-over-year revenue change (3.4% vs -11.4%). BT Brands, Inc. produced more free cash flow last quarter ($261.8K vs $-5.3M). Over the past eight quarters, Vivos Therapeutics, Inc.'s revenue compounded faster (5.8% CAGR vs -1.8%).

BT Group plc is a British multinational telecommunications holding company headquartered in London, England. It has operations in around 180 countries and is the largest provider of fixed-line, broadband and mobile services in the UK, and also provides subscription television and IT services.

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

BTBD vs VVOS — Head-to-Head

Bigger by revenue
BTBD
BTBD
1.0× larger
BTBD
$3.9M
$3.8M
VVOS
Growing faster (revenue YoY)
VVOS
VVOS
+14.8% gap
VVOS
3.4%
-11.4%
BTBD
Higher net margin
BTBD
BTBD
204.0% more per $
BTBD
23.7%
-180.3%
VVOS
More free cash flow
BTBD
BTBD
$5.6M more FCF
BTBD
$261.8K
$-5.3M
VVOS
Faster 2-yr revenue CAGR
VVOS
VVOS
Annualised
VVOS
5.8%
-1.8%
BTBD

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BTBD
BTBD
VVOS
VVOS
Revenue
$3.9M
$3.8M
Net Profit
$915.0K
$-6.9M
Gross Margin
78.1%
Operating Margin
19.1%
-166.8%
Net Margin
23.7%
-180.3%
Revenue YoY
-11.4%
3.4%
Net Profit YoY
516.9%
-143.8%
EPS (diluted)
$0.15
$-0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTBD
BTBD
VVOS
VVOS
Q4 25
$3.8M
Q3 25
$3.9M
$6.8M
Q2 25
$3.8M
$3.8M
Q1 25
$3.2M
$3.0M
Q4 24
$3.7M
Q3 24
$4.3M
$3.9M
Q2 24
$4.1M
$4.1M
Q1 24
$3.2M
$3.4M
Net Profit
BTBD
BTBD
VVOS
VVOS
Q4 25
$-6.9M
Q3 25
$915.0K
$-5.4M
Q2 25
$55.0K
$-5.0M
Q1 25
$-329.8K
$-3.9M
Q4 24
$-2.8M
Q3 24
$-219.5K
$-2.6M
Q2 24
$-70.0K
$-1.9M
Q1 24
$-445.7K
$-3.8M
Gross Margin
BTBD
BTBD
VVOS
VVOS
Q4 25
78.1%
Q3 25
58.0%
Q2 25
55.2%
Q1 25
50.0%
Q4 24
56.7%
Q3 24
60.5%
Q2 24
65.4%
Q1 24
56.7%
Operating Margin
BTBD
BTBD
VVOS
VVOS
Q4 25
-166.8%
Q3 25
19.1%
-69.8%
Q2 25
-2.0%
-127.4%
Q1 25
-9.0%
-129.9%
Q4 24
-75.9%
Q3 24
-1.7%
-68.5%
Q2 24
-4.6%
-47.8%
Q1 24
-19.8%
-110.7%
Net Margin
BTBD
BTBD
VVOS
VVOS
Q4 25
-180.3%
Q3 25
23.7%
-79.6%
Q2 25
1.5%
-131.2%
Q1 25
-10.2%
-128.1%
Q4 24
-76.4%
Q3 24
-5.0%
-67.8%
Q2 24
-1.7%
-47.6%
Q1 24
-14.0%
-110.1%
EPS (diluted)
BTBD
BTBD
VVOS
VVOS
Q4 25
$-0.58
Q3 25
$0.15
$-0.49
Q2 25
$-0.55
Q1 25
$-0.45
Q4 24
$0.41
Q3 24
$-0.04
$-0.40
Q2 24
$-0.60
Q1 24
$-1.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTBD
BTBD
VVOS
VVOS
Cash + ST InvestmentsLiquidity on hand
$3.5M
$2.0M
Total DebtLower is stronger
$2.9M
Stockholders' EquityBook value
$7.7M
$-1.5M
Total Assets
$11.9M
$25.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTBD
BTBD
VVOS
VVOS
Q4 25
$2.0M
Q3 25
$3.5M
$3.1M
Q2 25
$3.0M
$4.4M
Q1 25
$2.7M
$2.3M
Q4 24
$6.3M
Q3 24
$2.0M
$6.3M
Q2 24
$1.5M
$6.9M
Q1 24
$1.5M
$2.6M
Total Debt
BTBD
BTBD
VVOS
VVOS
Q4 25
$2.9M
Q3 25
Q2 25
Q1 25
Q4 24
$1.2M
Q3 24
$1.2M
Q2 24
$1.2M
Q1 24
Stockholders' Equity
BTBD
BTBD
VVOS
VVOS
Q4 25
$-1.5M
Q3 25
$7.7M
$2.5M
Q2 25
$6.8M
$4.6M
Q1 25
$6.7M
$4.4M
Q4 24
$8.0M
Q3 24
$8.5M
$7.7M
Q2 24
$8.7M
$6.3M
Q1 24
$8.8M
$582.0K
Total Assets
BTBD
BTBD
VVOS
VVOS
Q4 25
$25.2M
Q3 25
$11.9M
$25.6M
Q2 25
$11.2M
$26.0M
Q1 25
$11.0M
$11.3M
Q4 24
$15.3M
Q3 24
$13.7M
$15.3M
Q2 24
$14.0M
$15.8M
Q1 24
$14.0M
$11.8M
Debt / Equity
BTBD
BTBD
VVOS
VVOS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.15×
Q3 24
0.16×
Q2 24
0.19×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTBD
BTBD
VVOS
VVOS
Operating Cash FlowLast quarter
$325.2K
$-3.8M
Free Cash FlowOCF − Capex
$261.8K
$-5.3M
FCF MarginFCF / Revenue
6.8%
-139.7%
Capex IntensityCapex / Revenue
1.6%
40.0%
Cash ConversionOCF / Net Profit
0.36×
TTM Free Cash FlowTrailing 4 quarters
$-17.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTBD
BTBD
VVOS
VVOS
Q4 25
$-3.8M
Q3 25
$325.2K
$-4.2M
Q2 25
$384.4K
$-3.5M
Q1 25
$-306.7K
$-3.8M
Q4 24
$-2.9M
Q3 24
$129.3K
$-4.2M
Q2 24
$82.5K
$-3.0M
Q1 24
$-408.9K
$-2.5M
Free Cash Flow
BTBD
BTBD
VVOS
VVOS
Q4 25
$-5.3M
Q3 25
$261.8K
$-4.2M
Q2 25
$-4.3M
Q1 25
$-431.1K
$-3.9M
Q4 24
$-3.1M
Q3 24
$50.4K
$-4.4M
Q2 24
$53.7K
$-3.1M
Q1 24
$-521.3K
$-2.7M
FCF Margin
BTBD
BTBD
VVOS
VVOS
Q4 25
-139.7%
Q3 25
6.8%
-62.6%
Q2 25
-111.6%
Q1 25
-13.3%
-129.9%
Q4 24
-84.0%
Q3 24
1.2%
-113.4%
Q2 24
1.3%
-76.7%
Q1 24
-16.3%
-78.0%
Capex Intensity
BTBD
BTBD
VVOS
VVOS
Q4 25
40.0%
Q3 25
1.6%
1.2%
Q2 25
0.0%
20.2%
Q1 25
3.8%
4.0%
Q4 24
4.5%
Q3 24
1.8%
5.0%
Q2 24
0.7%
1.5%
Q1 24
3.5%
4.4%
Cash Conversion
BTBD
BTBD
VVOS
VVOS
Q4 25
Q3 25
0.36×
Q2 25
6.98×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BTBD
BTBD

Segment breakdown not available.

VVOS
VVOS

Services$3.2M84%
Products$594.0K16%

Related Comparisons